Compounding pharmacies will no longer be allowed to create semaglutide injections, a generic and cheaper version of Ozempic and Wegovy. This comes after a judge rejected a bid by these pharmacies to ...

Despite the decision being a win for Novo Nordisk, the compounded drugs sector is far too complex for this to be a final resolution.

Big compounders will have until May 22 to stop producing and dispensing compounded semaglutide, while smaller, state-run ...

Popular medications for obesity and diabetes have been linked to an increased risk of hair loss, particularly for women. Researchers and doctors weigh in.

Subscribe to Technology Networks’ daily newsletter, delivering breaking science news straight to your inbox every day. Subscribe for FREE Patients exploring weight-loss management strategies may elect ...

Compounding of another big-selling GLP-1 drug – Eli Lilly's tirzepatide – was blocked in December after that ... from compounded semaglutide to the FDA-approved brands before changing its ...

Sheu and colleagues additionally found that patients in the semaglutide group exhibited similar median HbA1c levels as controls before surgery (5.8% vs. 6%) and 1 year after surgery (5.5% vs.

A US judge has rejected efforts by a compounded drugs industry group to keep making an alternative version of Novo Nordisk’s popular drug semaglutide, opening the door for the US Food and Drug ...